发明名称 |
composição, métodos para reduzir um ou mais efeitos colaterais da terapia de glicocorticóide, e para tratar ou previnir um padrão de secreção de glicocorticóide endógeno diminuído ou interrompido em um paciente. |
摘要 |
The present invention relates to improved glucocorticoid therapy and to treatment or prevention of a number of disorders that are due to a diminished or disrupted endogenous glucocorticoid secretory pattern. The invention is based on the findings that producing a specific serum Cortisol time profile that mimics the circadian rhythm of Cortisol of a healthy subject in a subject suffering from a diminished or disrupted glucocorticoid secretory pattern gives benefits with respect to reduction of side-effects. |
申请公布号 |
BRPI1011624(A2) |
申请公布日期 |
2016.03.22 |
申请号 |
BR2010PI11624 |
申请日期 |
2010.04.07 |
申请人 |
DUOCORT PHARMA AB |
发明人 |
GUDMUNDUR JOHANNSSON;HANS LENNERNÄS;JÖRGEN JOHNSSON;STANKO SKRTIC;THOMAS HEDNER |
分类号 |
A61K31/573;A61P5/44 |
主分类号 |
A61K31/573 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|